Type 2 Diabetes Treatment
-
{
- All
- News
- Videos
-
New Study Explains Why Ozempic Doesn't Work For Everyone
A new study published in Genome Medicine details that Ozempic doesn't work for everyone in the same manner. Here is what you need to know about its mechanisms and why making science-based medical decisions is important.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Frequent Urination In Men: Early Sign Of Diabetes Or Prostate Issue?
Frequent urination is one of the early and most common symptoms of Type 2 Diabetes. When blood sugar levels rise, the kidneys work harder to filter and remove excess glucose from the body.
-
New Diabetes Generic Drug Gets Approval In US Market: All About Dapagliflozin
Zydus Lifesciences has received USFDA approval for generic dapagliflozin tablets used to treat type 2 diabetes. Here's how the drug works, its benefits, and why it is important for blood sugar control and heart health.
-
Liver Disease Identified As the 'Fourth Major Complication' Of Diabetes, Says Lancet Study
Researchers analysed over 9,000 patients using a tool called FibroScan, which measures liver stiffness without needles or surgery.
-
This Is Exactly Why You Must Combat Insulin Resistance Immediately
If the pancreas can no longer manage high blood sugar (hyperglycemia), significant, long-term health issues can arise.
-
Metformin Vs Ozempic: Which Popular Diabetes Drug Improves Blood Sugar Control With Lesser Side Effects?
Metformin is usually the first-choice for the treatment of type 2 diabetes. This drug mainly works by lowering glucose production in the liver. It also helps your body respond better to insulin.
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Heart Benefits Fade After You Stop Taking GLP-1 Drugs: Study
This study, published in BMJ Medicine, investigated what happens when people with Type 2 diabetes stop or interrupt their treatment with GLP-1 drugs.
-
Wegovy Users Have 5x Higher Vision Loss Risk Than Ozempic, New Study Finds
A new study found that users of Wegovy have nearly five times the risk of ischemic optic neuropathy (ION), compared to Ozempic users. ION, also known as 'eye stroke', is a condition that happens due to reduced blood flow to the optic nerve.
-
Popular Weight Loss Drugs May Help Reduce Risk of Substance Use Disorders, Suggests New Study
A new study published in The BMJ says that GLP-1 drugs may help prevent and treat substance use disorders across all major addictive substances that were studied.
-
Neonatal Diabetes Alert: Doctor Shares Breastfeeding Tips That Protect Babies
Neonatal diabetes is fundamentally different from the Type 2 diabetes that is seen in adults.
-
Stem Cell Therapy Breakthrough: Type 2 Diabetes Reversed In Historic Case In China
Chinese scientists have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Here is what you need to know about the breakthrough and why it matters for the world and for India.
-
What's India's Average BMI? How National Guidelines Differ From Global Norms
Indians face higher diabetes and heart risks at lower body mass index (BMI) levels than Western populations.
-
New Study Explains Why Ozempic Doesn't Work For Everyone
A new study published in Genome Medicine details that Ozempic doesn't work for everyone in the same manner. Here is what you need to know about its mechanisms and why making science-based medical decisions is important.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
Frequent Urination In Men: Early Sign Of Diabetes Or Prostate Issue?
Frequent urination is one of the early and most common symptoms of Type 2 Diabetes. When blood sugar levels rise, the kidneys work harder to filter and remove excess glucose from the body.
-
New Diabetes Generic Drug Gets Approval In US Market: All About Dapagliflozin
Zydus Lifesciences has received USFDA approval for generic dapagliflozin tablets used to treat type 2 diabetes. Here's how the drug works, its benefits, and why it is important for blood sugar control and heart health.
-
Liver Disease Identified As the 'Fourth Major Complication' Of Diabetes, Says Lancet Study
Researchers analysed over 9,000 patients using a tool called FibroScan, which measures liver stiffness without needles or surgery.
-
This Is Exactly Why You Must Combat Insulin Resistance Immediately
If the pancreas can no longer manage high blood sugar (hyperglycemia), significant, long-term health issues can arise.
-
Metformin Vs Ozempic: Which Popular Diabetes Drug Improves Blood Sugar Control With Lesser Side Effects?
Metformin is usually the first-choice for the treatment of type 2 diabetes. This drug mainly works by lowering glucose production in the liver. It also helps your body respond better to insulin.
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Heart Benefits Fade After You Stop Taking GLP-1 Drugs: Study
This study, published in BMJ Medicine, investigated what happens when people with Type 2 diabetes stop or interrupt their treatment with GLP-1 drugs.
-
Wegovy Users Have 5x Higher Vision Loss Risk Than Ozempic, New Study Finds
A new study found that users of Wegovy have nearly five times the risk of ischemic optic neuropathy (ION), compared to Ozempic users. ION, also known as 'eye stroke', is a condition that happens due to reduced blood flow to the optic nerve.
-
Popular Weight Loss Drugs May Help Reduce Risk of Substance Use Disorders, Suggests New Study
A new study published in The BMJ says that GLP-1 drugs may help prevent and treat substance use disorders across all major addictive substances that were studied.
-
Neonatal Diabetes Alert: Doctor Shares Breastfeeding Tips That Protect Babies
Neonatal diabetes is fundamentally different from the Type 2 diabetes that is seen in adults.
-
Stem Cell Therapy Breakthrough: Type 2 Diabetes Reversed In Historic Case In China
Chinese scientists have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Here is what you need to know about the breakthrough and why it matters for the world and for India.
-
What's India's Average BMI? How National Guidelines Differ From Global Norms
Indians face higher diabetes and heart risks at lower body mass index (BMI) levels than Western populations.
